Diabetes and Stroke: What Are the Connections?
Journal of Stroke · 31.01.2023 · 25 (1) · 26-38
DOI: 10.5853/jos.2022.02306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Stroke, erschienen am 31.01.2023. Verfasst von Ofri Mosenzon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel. Die Arbeit wurde bisher 251-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ashfield MedComms.
Themen: Diabetes mellitus, Schlaganfall
Abstract (Originalsprache)
Stroke is a major cause of death and long-term disability worldwide. Diabetes is associated with an increased risk of cardiovascular complications, including stroke. People with diabetes have a 1.5–2 times higher risk of stroke compared with people without diabetes, with risk increasing with diabetes duration. These risks may also differ according to sex, with a greater risk observed among women versus men. Several mechanisms associated with diabetes lead to stroke, including large artery atherosclerosis, cerebral small vessel disease, and cardiac embolism. Hyperglycemia confers increased risk for worse outcomes in people presenting with acute ischemic stroke, compared with people with normal glycemia. Moreover, people with diabetes may have poorer post-stroke outcomes and higher risk of stroke recurrence than those without diabetes. Appropriate management of diabetes and other vascular risk factors may improve stroke outcomes and reduce the risk for recurrent stroke. Secondary stroke prevention guidelines recommend screening for diabetes following a stroke. The diabetes medications pioglitazone and glucagon-like peptide-1 receptor agonists have demonstrated protection against stroke in randomized controlled trials; this protective effect is believed to be independent of glycemic control. Neurologists are often involved in the management of modifiable risk factors for stroke (including hypertension, hyperlipidemia, and atrial fibrillation), but less often in the direct management of diabetes. This review provides an overview of the relationships between diabetes and stroke, including epidemiology, pathophysiology, post-stroke outcomes, and treatments for people with stroke and diabetes. This should aid neurologists in diabetes-related decision-making when treating people with acute or recurrent stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada.
- Division of Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Förderung
- Ashfield MedComms
Zitieren
APA
Mosenzon, O., Cheng, A. Y., Rabinstein, A. A., & Sacco, S. (2023). Diabetes and Stroke: What Are the Connections?. Journal of Stroke, 25(1), 26-38. https://doi.org/10.5853/jos.2022.02306
Vancouver
Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Diabetes and Stroke: What Are the Connections?. Journal of Stroke. 2023;25(1):26-38. doi:10.5853/jos.2022.02306
BibTeX
@article{Mosenzon2023,
author = {Mosenzon, Ofri and Cheng, Alice Yy and Rabinstein, Alejandro A and Sacco, Simona},
title = {Diabetes and Stroke: What Are the Connections?},
journal = {Journal of Stroke},
year = {2023},
volume = {25},
number = {1},
pages = {26--38},
doi = {10.5853/jos.2022.02306}
}
EUVIMED